Veenat 400 pack, imatinib by Natco
Prescription cancer medicine

Imatinib

Brand reference: Gleevec, Glivec, Imatib, Veenat

Chronic myeloid leukaemia and GIST (tyrosine kinase inhibitor).

FormTabletStrengths shown100 mg, 400 mgPrescriptionRequired
Add to enquiry list

Add this medicine to a consolidated enquiry. This does not reserve stock, create an order or confirm availability.

What is Imatinib used for?

Chronic myeloid leukaemia (CML) Gastrointestinal stromal tumour (GIST) Other Philadelphia-chromosome-positive conditions

A targeted therapy used for certain leukaemias and gastrointestinal stromal tumours. Availability is reviewed case by case.

In simple terms

Imatinib is a tyrosine-kinase inhibitor. It precisely blocks the abnormal BCR-ABL signal that drives CML cells to multiply - one of the first true targeted cancer therapies.

Brand and medicine details

Active ingredient
Imatinib
Dispensing location
Confirmed only if an enquiry can proceed.
Brand references
Gleevec, Glivec, Imatib, Veenat
Strengths shown
100 mg, 400 mg
Dosage form
Tablet

A catalogue brand reference does not confirm the manufacturer, pack, source or availability for an individual enquiry. Confirm any proposed substitution with the treating oncology team.

How it may be prescribed

Usually taken once daily with food and a large glass of water, as the oncologist prescribes. Taken long-term with regular monitoring.

Possible side effects to discuss with the care team

  • Fluid retention and puffiness
  • Nausea, muscle cramps
  • Low blood counts (monitored)
  • Rash
Important safety information

Specialist supervision with regular blood tests. Supplied only against a valid specialist prescription.

Common questions about Imatinib

Is generic Imatinib genuine medicine?

Yes. Medrack refers only licensed medicine from a controlled supply chain, either the originator brand or a licensed branded generic from an established manufacturer. It is not an unbranded or unverified copy. The exact brand, manufacturer and pack are confirmed at the enquiry stage, and any proposed medicine should be reviewed with the treating oncology team.

Do I need a prescription for Imatinib?

Yes. Imatinib is a prescription medicine. You can start an enquiry before you have the prescription in hand, but nothing proceeds until a current prescription issued in the patient's name has been received and checked. You upload it privately as part of the enquiry.

What happens after you enquire

Every enquiry is assessed individually. A listing on this page does not confirm availability, a dispensing pharmacy or a delivery.

  1. You send an enquiry

    Add the prescribed medicine and upload the current prescription. This records a request for assessment, not an order.

  2. We check the prescription

    The medicine, prescription, patient details, destination and supporting documentation are reviewed case by case.

  3. We prepare a referral and written terms

    Any proposal identifies the responsible dispensing party, the dispensing country, the total charges and the cancellation terms.

  4. You confirm and pay

    Nothing proceeds until you accept the disclosed terms. Payment is requested only after that written summary has been provided.

  5. Dispatch and delivery

    Dispatch and delivery dates are estimates. Timing can change with availability, documentation, customs or regulatory decisions outside our control.

Full detail is in delivery and fulfilment, order and fulfilment terms and cancellation and refunds.

Before you send an enquiry

These guides explain what to check and what to ask, so the enquiry arrives complete.

Build an enquiry list

Add Imatinib

Choose the prescribed strength and quantity. You can add more medicines before sending one enquiry.

Adding a medicine does not reserve stock or create an order.

This listing does not support starting, stopping, switching or changing treatment. Keep the treating oncology team involved in all clinical decisions and monitoring.